05/13/2024 7:01 AM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 7:05 AM | UroGen Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024 1:22 PM | BlackRock Inc. (Filed by) UroGen Pharma (Subject)
| Form SC 13G/A | |
04/29/2024 7:18 AM | UroGen Pharma (Filer)
| Form 10-K/A | |
03/20/2024 3:38 PM | Schoenberg Mark (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 12:48 PM | Schoenberg Mark (Reporting) UroGen Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024 7:16 AM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
03/14/2024 7:17 AM | UroGen Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/04/2024 6:00 AM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 6:00 AM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 8:23 AM | Arkin Moshe (Filed by) UroGen Pharma (Subject)
| Form SC 13D/A | |
02/14/2024 6:07 AM | RTW INVESTMENTS, LP (Filed by) UroGen Pharma (Subject)
| Form SC 13G | |
02/12/2024 4:47 PM | Kim Dong (Reporting) UroGen Pharma (Issuer)
| Form 4/A | |
02/12/2024 4:43 PM | Kim Dong (Reporting) UroGen Pharma (Issuer)
| Form 4/A | |
02/07/2024 3:15 PM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2024 8:15 PM | Schoenberg Mark (Reporting) UroGen Pharma (Issuer)
| Form 4/A | |
02/05/2024 8:16 PM | Smith Jason Drew (Reporting) UroGen Pharma (Issuer)
| Form 4/A | |
02/02/2024 6:04 PM | Barrett Elizabeth A. (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:05 PM | Kim Dong (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:07 PM | Schoenberg Mark (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:12 PM | Smith Jason Drew (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:18 PM | BlackRock Inc. (Filed by) UroGen Pharma (Subject)
| Form SC 13G | |
02/01/2024 9:13 AM | Schoenberg Mark (Reporting) UroGen Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024 8:53 AM | Smith Jason Drew (Reporting) UroGen Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024 3:16 PM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 7:04 AM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 3:30 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) UroGen Pharma (Subject)
| Form SC 13G | |
11/14/2023 3:20 PM | UroGen Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/17/2023 11:15 PM | UroGen Pharma (Filer)
| Form EFFECT | |
09/15/2023 12:39 PM | GREAT POINT PARTNERS LLC (Filed by) UroGen Pharma (Subject)
| Form SC 13G | |
09/11/2023 3:15 PM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2023 3:16 PM | UroGen Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
09/08/2023 2:40 PM | Schoenberg Mark (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 2:41 PM | Kim Dong (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 2:41 PM | Smith Jason Drew (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 2:41 PM | UroGen Pharma (Issuer) WEN LEANA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 2:41 PM | Robinson James A. Jr. (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 2:42 PM | Holden Stuart (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 2:42 PM | UroGen Pharma (Issuer) Wildman Daniel George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 2:42 PM | Cohen Fred E (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 2:43 PM | BUTITTA CYNTHIA M (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… |
09/08/2023 2:43 PM | Belldegrun Arie (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 3:28 PM | Smith Jason Drew (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 1:06 PM | UroGen Pharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
08/10/2023 7:01 AM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 7:04 AM | UroGen Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/04/2023 7:56 AM | Monograph Capital Holdings Advisors, LLC (Filed by) UroGen Pharma (Subject)
| Form SC 13D | |
08/01/2023 3:27 PM | UroGen Pharma (Filer)
| Form ARS | |
07/28/2023 5:05 PM | Robinson James A. Jr. (Reporting) UroGen Pharma (Issuer)
| Form 4/A | |
07/28/2023 5:06 PM | Cohen Fred E (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/27/2023 8:57 AM | UroGen Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2023 7:47 AM | MENORA MIVTACHIM HOLDINGS LTD. (Filed by) UroGen Pharma (Subject)
| Form SC 13G/A | |
06/09/2023 2:26 PM | Schoenberg Mark (Reporting) UroGen Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |